| CLA1681 |
|
906068-56-2 |
西拉利珠單抗
Theralizumab | TGN1412 | TAB-08 | TABO8
3-5days
95+%
|
￥3236.00 |
— |
|
|
|
| CLA1634 |
|
2226212-40-2 |
塔奎妥單抗
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab； JNJ-64407564； JNJ-7564)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1610 |
|
2413817-97-5 |
格瑞妥單抗
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab； AMG 910; )
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1601 |
|
1801338-64-6 |
奧尼妥單抗
Anti-Human CD3ExCD20 Bispecific Antibody(Odronextamab)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1589 |
|
2134641-34-0 |
艾可瑞妥單抗
Anti-Human CD3ExCD20 (Epcoritamab; GEN3013)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1553 |
|
2119595-80-9 |
特立妥單抗
Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab )
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1510 |
|
2101242-53-7 |
賽必妥單抗
Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1489 |
|
1905409-39-3 |
莫妥珠單抗
Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A； R07030816；CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1360 |
|
1442657-12-6 |
帕妥昔珠單抗
Pasotuxizumab
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1356 |
|
1630074-14-4 |
地寧妥珠單抗
Denintuzumab (Anti-CD19)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1354 |
|
946415-62-9 |
昂妥昔珠單抗
Ontuxizumab (Anti-TEM1 / Endosialin / CD248)
3-5days
95+%
|
￥3200.00 |
— |
|
|
|
| CLA1353 |
|
1269764-99-9 |
考妥昔單抗
Coltuximab (Anti-CD19)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1345 |
|
1416147-64-2 |
達(dá)匹利珠單抗
Dapirolizumab pegol
3-5days
95+%
|
￥6200.00 |
— |
|
|
|
| CLA1324 |
|
1313706-14-7 |
匹那妥珠單抗
Pinatuzumab (Anti-Siglec-2 / CD22)
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1308 |
|
1169956-08-4 |
奧卡妥珠單抗
Ocaratuzumab (Anti-CD20)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1293 |
|
1005198-65-1 |
索利托單抗
Solitomab
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1287 |
|
1238217-55-4 |
伐利組單抗
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1282 |
|
1188275-92-4 |
那吶妥單抗
Narnatumab (Anti-MSPR / RON / CD136)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1275 |
|
934823-49-1 |
烏瑞蘆單抗
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)
3-5days
95+%
|
￥5500.00 |
— |
|
|
|
| CLA1274 |
|
1174014-05-1 |
烏妥昔單抗
Ublituximab (Anti-CD20)
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
